Delta 9 Announces Cost Cutting Measures as a Part of 2023 Strategic Plan; Charts Path to Becoming Positive Cash Flow from Operations
January 09 2023 - 5:00AM
DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the
“Company”), announces various cost cutting measures as a part of
the Company’s 2023 strategic plan with the goal of producing
positive cash flow from operations.
As a part of the 2023 strategic plan the Company
plans to streamline its cultivation operations and right-size
capacity at its Winnipeg based cultivation facilities, as well as
various other cost cutting measures including reducing public
company and investor relations costs.
“Delta 9’s retail operations have achieved
profitability and positive operating cash flows over the past
several years,” said Mark Jonker, COO of Delta 9, “Our cultivation
and wholesale cannabis operations have struggled with profitability
due to continued price and margin compression in the Canadian
cannabis market. Our decision is designed to significantly reduce
costs and to chart a near term path to becoming positive cash flow
from operations.”
“We recognize that in the current market
environment we need to make near term strides to improve
profitability across our operations. The Board of Directors and
executive have also agreed to reducing compensation as part of
their commitment to achieving positive cash flows from operations
in the current fiscal year,” said Jim Lawson, CFO of Delta 9, “The
cost savings are expected to reduce operating costs by $3 Million
to $4 Million in 2023.”
As a part of the plan, cultivation capacity at
the Company’s Winnipeg based cultivation facilities will be cut by
approximately 40%, which will include a temporary layoff of
approximately 40 staff. The plan has been developed to ensure that
there is no material impact on wholesale revenues or on shipments
to the Company’s wholesale and retail customers. Delta 9 is working
closely with employees to reduce the impact of this decision
including continuing to cover costs for Company benefits and other
transitional services. The Company’s retail operations will not be
impacted as a part of this plan.
“I would like to thank the employees affected by
this decision for their invaluable contributions to Delta 9’s
success and growth,” said John Arbuthnot, CEO of Delta 9, “This was
a very difficult decision, but it is a key component of executing
on our strategic plan and one we believe best positions Delta 9 for
profitable growth”
For more information contact:
Investor & Media
Contact:Ian Chadsey VP Corporate
AffairsMobile:
204-898-7722E-mail: ian.chadsey@delta9.ca
About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated
cannabis company focused on bringing the highest quality cannabis
products to market. The company sells cannabis products through its
wholesale and retail sales channels and sells its cannabis grow
pods to other businesses. Delta 9's wholly-owned subsidiary, Delta
9 Bio-Tech Inc., is a licensed producer of medical and recreational
cannabis and operates an 80,000 square foot production facility
in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a
chain of retail stores under the Delta 9 Cannabis Store brand.
Delta 9's shares trade on the Toronto Stock Exchange under the
symbol "DN" and on the OTCQX under the symbol "DLTNF". For more
information, please visit www.invest.delta9.ca.
Disclaimer for Forward-Looking Information
Certain statements in this release are
forward-looking statements, which reflect the expectations of
management regarding the Company’s future business plans and other
matters. Forward-looking statements consist of statements that are
not purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future. Forward
looking statements in this news release include statements relating
to the Company’s expansion plans. Such statements are subject to
risks and uncertainties that may cause actual results, performance
or developments to differ materially from those contained in the
statements, including all risk factors set forth in the annual
information form of Delta 9 dated March 31, 2022 which
has been filed on SEDAR. No assurance can be given that any of the
events anticipated by the forward-looking statements will occur or,
if they do occur, what benefits the Company will obtain from them.
Readers are urged to consider these factors carefully in evaluating
the forward-looking statements contained in this news release and
are cautioned not to place undue reliance on such forward-looking
statements, which are qualified in their entirety by these
cautionary statements. These forward-looking statements are made as
of the date hereof and the Company disclaims any intent or
obligation to update publicly any forward-looking statements,
whether as a result of new information, future events or results or
otherwise, except as required by applicable securities laws.
Delta 9 Cannabis (TSX:DN)
Historical Stock Chart
From Dec 2024 to Jan 2025
Delta 9 Cannabis (TSX:DN)
Historical Stock Chart
From Jan 2024 to Jan 2025